Merck Extends Timeline On Acceleron Deal, Still Expects Q4 Close

Some Investors Have Voiced Concern About Buyout

Sand running through an hourglass
Time is not running out yet to close Merck's Acceleron acquisition • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business